Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
462.14
-7.62 (-1.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
52
53
Next >
3 Small Financial Software Makers Showing Strong Chart Action
March 28, 2023
Financial software firms Intapp, Vertex, and GuidewIre are headed toward greater profitability and also boast strong chart action.
Via
MarketBeat
Bullish News May Push Vertex Pharmaceuticals Above 52-Week High
March 28, 2023
A recent announcement by Vertex Pharmaceuticals is confirming a technical signal that could allow the stock to make a new run at its 52-week high
Via
MarketBeat
Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
March 27, 2023
In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier.
Via
Investor's Business Daily
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes
March 27, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
How Is The Market Feeling About Vertex Pharmaceuticals?
March 23, 2023
Via
Benzinga
10 Analysts Have This to Say About Vertex Pharmaceuticals
March 21, 2023
Via
Benzinga
2 Explosive Stocks That Could Go Parabolic
March 09, 2023
Don't let these stocks pass you by when you go shopping for more wonderful businesses.
Via
The Motley Fool
Could CRISPR Therapeutics Become the Next Moderna?
March 27, 2023
Both companies use cutting-edge technology.
Via
The Motley Fool
Want $1 Million in Retirement? Buy and Hold These 5 Stocks
March 26, 2023
There's no guarantee that you'll be a millionaire retiree. But these stocks could improve your odds.
Via
The Motley Fool
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.
Via
InvestorPlace
Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend
March 25, 2023
These red-hot stocks keep climbing despite the bear market.
Via
The Motley Fool
This Is My Highest-Conviction Stock to Own in 2023 and Beyond
March 23, 2023
This company has already delivered market-beating returns, but it's not too late to get in.
Via
The Motley Fool
Got $3,000? 3 Growth Stocks to Double Up on Right Now
March 23, 2023
The great prospects for these stocks make them worthy of bigger bets.
Via
The Motley Fool
BioMarin Pharmaceutical Stock Sees IBD RS Rating Improve To 74
March 21, 2023
A Relative Strength Rating upgrade for BioMarin Pharmaceutical shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Via
Benzinga
The Best Stocks to Invest $20,000 in Right Now
March 21, 2023
These businesses are already strong, but they could grow much larger.
Via
The Motley Fool
3 Monster Stocks to Buy Without Any Hesitation
March 20, 2023
These stocks are monsters now. They'll probably be much bigger monsters over the next decade and beyond.
Via
The Motley Fool
3 Surefire Stocks That Can Thrive During a Recession
March 20, 2023
These time-tested businesses have the sustainable cash flow and catalysts needed to outperform when the U.S. economy isn't at its best.
Via
The Motley Fool
12-Stock Portfolio -- 25 Growth Stocks to Buy Now
March 19, 2023
If I were starting a new growth stock portfolio today, here are the stocks I'd buy.
Via
The Motley Fool
Worried About the Banking Turmoil? These 3 Stocks Shouldn't Skip a Beat
March 19, 2023
Investors can sleep peacefully owning these stocks.
Via
The Motley Fool
3 Pharma Stocks That Could Benefit from Global Healthcare Trends
March 17, 2023
The best pharma stocks to buy are those that are poised to be greatly boosted by drugs that are well-positioned to become blockbusters.
Via
InvestorPlace
Exelixis Stock Generating Improved Relative Strength Rating
March 16, 2023
Exelixis stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 69 to 76.
Via
Investor's Business Daily
Vertex Announces Publication in New England Journal of Medicine of Results from Phase 2 Study of Inaxaplin (VX-147)
March 16, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
March 15, 2023
These companies have what it takes to grow their revenues -- and their share prices -- over time.
Via
The Motley Fool
Vertex Pharmaceuticals Stock Gets Technical Rating Upgrade
March 13, 2023
Vertex Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 67 to 77.
Via
Investor's Business Daily
Prediction: These 3 Stocks Will Be in the Dow by 2030
March 13, 2023
Being added to the Dow Jones Industrial Average would just be another feather in the cap for these successful stocks.
Via
The Motley Fool
3 Supercharged Stocks With More Potential Than Any Cryptocurrency
March 12, 2023
These growth stocks are going from strength to strength.
Via
The Motley Fool
This HealthCare Company Is Gearing Up for Its Next Launch: Here Is Why The Stock Is a Buy
March 10, 2023
The company's future in the stock market could look very much like its past.
Via
The Motley Fool
2 Top Stocks to Buy in March and Hold Forever
March 09, 2023
Don't let a turbulent market keep you on the sidelines this month.
Via
The Motley Fool
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
52
53
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.